Correction to: Cell Death & Disease https://doi.org/10.1038/s41419-022-05085-0, published online 18 July 2022
The original version of this article contained a mistake in an author name. Bing Ni needs to be corrected to Bin Ni. In addition, the affiliations of the corresponding author should be 1, 2, 3, 4, 5, 6, 7. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Han, X., de Dieu Habimana, J., Li, A.L. et al. Correction: Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model. Cell Death Dis 13, 654 (2022). https://doi.org/10.1038/s41419-022-05119-7
Published:
DOI: https://doi.org/10.1038/s41419-022-05119-7
